Study Evaluating Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain

Long-Term Safety Study of Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain

The purpose of this study is to evaluate long-term safety of etanercept in patients with rheumatoid arthritis who successfully have completed open-label safety study 0881A1-301-EU

Inclusion Criteria:

• To have completed 0881A1-301-EU study in Spain
• Clinical diagnosis by ACR revised criteria of rheumatoid arthritis.

Exclusion Criteria:

• Hypersensibility to etanercept or any of its components
• Significant concurrent medical disease